Haloub, Radi and Anchor, J.R (2014) Hikma Pharmaceuticals: an Emerging Markets Multinational. EFMD. (Unpublished)
- Draft Version
Restricted to Registered users only until 6 November 2016.
In Middle East and North Africa (MENA) countries, the business environment remains unsettled due to rapid changes in governments which would create of new business opportunities. The pharmaceutical market is one of the steadily growing markets in MENA due to the increase in the size and number of new hospitals.
Hikma Pharmaceuticals is a multinational pharmaceutical group which operates in the MENA region, the USA and Europe. Hikma started to produce and market generics in local markets in 1978 and became listed on the London stock exchange in 2005, reaching over US$1 billion turnover after three decades and having presence in more than 50 markets. The massive growth of this global company initiated via high investments and successful strategies in different market entries.
The globalisation strategy has enabled Hikma to penetrate many markets and to become a globally recognised pharmaceutical company. This case presents a globally recognised company from MENA as an Emerging Markets Multinational.
|Additional Information:||Entered in EFMD Case Writing Competition 2014|
|Subjects:||H Social Sciences > HD Industries. Land use. Labor > HD28 Management. Industrial Management
R Medicine > RS Pharmacy and materia medica
|Schools:||The Business School
The Business School > Emerging Markets Research Group
|Depositing User:||Radi Haloub|
|Date Deposited:||17 Sep 2015 13:04|
|Last Modified:||07 Jun 2016 13:09|
Downloads per month over past year
Repository Staff Only: item control page